Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.44M P/E - EPS this Y 67.50% Ern Qtrly Grth -
Income -123.42M Forward P/E -0.23 EPS next Y 52.70% 50D Avg Chg -40.00%
Sales 3.99M PEG - EPS past 5Y - 200D Avg Chg -69.00%
Dividend N/A Price/Book 0.06 EPS next 5Y - 52W High Chg -91.00%
Recommedations 2.00 Quick Ratio 0.48 Shares Outstanding 58.61M 52W Low Chg 2.00%
Insider Own 0.01% ROA -40.51% Shares Float 21.05M Beta 2.29
Inst Own 28.61% ROE -69.20% Shares Shorted/Prior 0.97M/596.50K Price 1.01
Gross Margin 40.49% Profit Margin - Avg. Volume 395,326 Target Price 5.63
Oper. Margin -705.62% Earnings Date Mar 28 Volume 677,560 Change -1.94%
About Tonix Pharmaceuticals Holding C

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its development portfolio focuses on central nervous system disorders. The company's priority is to submit a New Drug Application (NDA) to the FDA for TNX-102 SL (cyclobenzaprine HCl sublingual tablet), which has completed two positive Phase 3 studies for the management of fibromyalgia. TNX-102 SL is also being developed to treat fibromyalgia-type Long COVID, a chronic post-acute COVID-19 condition. Its TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted breakthrough therapy designation by the FDA. The company's rare disease development portfolio comprises TNX-2900, an intranasal potentiated oxytocin for the treatment of Prader-Willi syndrome (PWS). Its immunology development portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. The company's infectious disease pipeline includes TNX-801, a vaccine in development to prevent smallpox and mpox. TNX-801 also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases, including TNX-1800, in development as a vaccine to protect against COVID-19. Its infectious disease development portfolio also comprises TNX-3900 and TNX-4000, which are classes of broad-spectrum small molecule oral antivirals. The company was founded in 2007 and is headquartered in Chatham, New Jersey.

Tonix Pharmaceuticals Holding C News
03/28/24 Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
03/25/24 Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
03/21/24 Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting
03/20/24 Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia
03/19/24 Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024
03/12/24 Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring
03/12/24 TNXP: Tonmya™ May Launch Alongside Another New Fibromyalgia Treatment…
03/11/24 Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia
03/07/24 New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT
03/07/24 Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy
03/06/24 Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia
03/05/24 Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans
08:00 AM Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia
02/28/24 Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers
02/28/24 Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial
02/28/24 Tonix Pharmaceuticals' Fibromyalgia Trial Shows Promising Results in Webinar Presentation
02/27/24 Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China
02/26/24 New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain
02/25/24 3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
02/23/24 New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series
TNXP Chatroom

User Image Happy_Feet19 Posted - 2 hours ago

$TNXP Have they held a virtual or in person meeting to vote on a Reverse Split yet?

User Image Happy_Feet19 Posted - 2 hours ago

$TNXP The only near team catalyst per the company presentation on their website for March, 2024 is the following: TNX-1500 P1 Read out 3Q24 It looks pretty low on their presentation review. Any thoughts with chat members about this Trial Readout in 3Q24?

User Image shortiestacks9 Posted - 4 hours ago

$TNXP where is that stupid fuck that believes this won't reverse split before may 24? for all the fleeced newbies: if this make compliace by some random act of fraud, sell and never hold this again. either day trade - if possible or short.

User Image Luka_Brasi Posted - 5 hours ago

$TNXP Mr Lederman has made himself quite wealthy off this POS. How are you doing, who's smarter in this relationship?

User Image UncleAlbie Posted - 5 hours ago

$TNXP Worst investment ever... Seth, sell the damn company to BP.

User Image bullsheeeeeter Posted - 5 hours ago

$TNXP tutes want all shares…you will own nothing and be happy…

User Image Bigstud98 Posted - 5 hours ago

$TNXP This SCAM had 5 R/Ss in the last 7 years. This should be call Toxic. Not Tonix. lol

User Image Raythewinner Posted - 6 hours ago

$TNXP 🙄

User Image squidgy Posted - 7 hours ago

$TNXP this is a joke - Seth is a joke. There’s a saying - ‘make a fool of me once, shame on you, make a fool of my twice - shame on me!’

User Image Liveitt Posted - 7 hours ago

$TNXP am I f****ed? And I used to have 8000 shares was $1200 in green before all the reverse splits and shit I was clueless… should I buy at 0.20 now to bring down my average from $32…I am still clueless what to do. Any advise much appreciated

User Image jawknee84 Posted - 8 hours ago

User Image Game4bet Posted - 8 hours ago

$TNXP only dilution here, bulls idiots, attention!

User Image momeymaker1 Posted - 8 hours ago

$TNXP one of the most toxic bio ticker around.

User Image premarketmaker Posted - 8 hours ago

$TNXP another offering 14.7M shares at .3

User Image bullsheeeeeter Posted - 8 hours ago

$TNXP Seth for the most part just erased the hedge funds losses from all 3 offerings in 2023 ! …. One of the offerings was 1.00 and Tonix amended to .33 cents… that offering alone just saved the hedges 70% of losses which was basically a 7 million dollar buy…. When you think it can’t get any sketchier… it does🤦 Giving it serious thought WHEN I will buy more…

User Image bonifacius Posted - 8 hours ago

$TNXP Could it be that they did not get the extension? I mean inside information moves fast in certain circles 🙄 It explains todays action...

User Image shortiestacks9 Posted - 9 hours ago

$TNXP where's bullsheeeter???

User Image squidgy Posted - 9 hours ago

$TNXP in theory 4.4million purchase should take it back to 0,30

User Image Redvip Posted - 9 hours ago

$TNXP added a bit more for the rebound

User Image dtmadtown Posted - 9 hours ago

$TNXP Will the last person to leave the room please turn off the lights.

User Image squidgy Posted - 9 hours ago

$TNXP watch Seth do another offering at 0.10 cents and still manage to convince the investors to put in more!!!! Despite r/s imminent.

User Image squidgy Posted - 9 hours ago

$TNXP I don’t understand why an investor would do a direct investment of 4million knowing the stock would nose dive unless they do it because they are shorting the stock with much bigger amounts.

User Image StockStreet Posted - 9 hours ago

$TNXP The worst still to come. Most dreaded aspect of holding on to this stock: killer RS action. Comes fast and furious. No vote, no shareholders consent. No nothing. Baaam 😅 Shareholder Slaughter House Corp.

User Image OpenOutcrier Posted - 9 hours ago

RECAP 3/28 Chatter: $NVO + Wegovy coverage $TNXP - Offering $HD - Suspends Buybacks $VMEO - Bending Spoon out Live Breaking trading news www.openoutcrier.com

User Image Thespectator Posted - 9 hours ago

$TNXP this is legalized highway robbery, thank you SEC!

User Image thenarrativeiscrumbling Posted - 9 hours ago

$TNXP Gary gensler is there to enrich his and seths tribe. simple

User Image thenarrativeiscrumbling Posted - 9 hours ago

$TNXP the SEC are to thank for this fraud

User Image Dyk_Smalls Posted - 9 hours ago

$TNXP

User Image thenarrativeiscrumbling Posted - 9 hours ago

$TNXP .18 cent wow. Seths tribe are a scourge on the nation. Not to mention how much of our taxes they drain currently

User Image Nas1898 Posted - 10 hours ago

$TNXP back to dream , you can sleep No hope here

Analyst Ratings
Dawson James Buy Feb 28, 24
Alliance Global Partners Buy Aug 1, 23
Alliance Global Partners Buy Jun 2, 23
Alliance Global Partners Buy Aug 31, 21
Alliance Global Partners Buy Aug 11, 21
Alliance Global Partners Buy Feb 25, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LEDERMAN SETH Chief Executive Offi.. Chief Executive Officer Mar 25 Buy 0.245 100,000 24,500 112,177 03/28/22